Device General - Brady_crm

General - Brady

Payments companies reported to CMS as associated with General - Brady. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$300Kassociated payments (2023-2025)
827clinicians with associated payments
1company reporting

By year

2025 $300K

Payments reported as associated with General - Brady, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $157K
Cardiovascular Disease $58K
Internal Medicine $44K
Interventional Cardiology $4,981
Advanced Heart Failure and Transplant Cardiology $1,890
Family $1,633

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with General - Brady

These are the largest totals companies reported as associated with General - Brady. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Matthew Carlisle Greensboro, NC Clinical Cardiac Electrophysiology $14,357.05
Brian Betensky Sarasota, FL Clinical Cardiac Electrophysiology $14,100.00
Margaret Infeld Boston, MA $10,625.00
Roderick Tung Chicago, IL Clinical Cardiac Electrophysiology $10,625.00
Robert Schaller Philadelphia, PA Clinical Cardiac Electrophysiology $10,625.00
Michael Jiang Los Angeles, CA Internal Medicine $10,010.34
Akash Makkar Phoenix, AZ Clinical Cardiac Electrophysiology $9,124.52
Rizwan Alimohammad Albany, NY Cardiovascular Disease $8,175.00
Raktham Mekritthikrai Chicago, IL Clinical Cardiac Electrophysiology $7,500.00
Michael Dietrich Chicago, IL Cardiovascular Disease $7,500.00

Prescribed General - Brady?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.